{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:21:08Z","timestamp":1793942468920,"version":"4.8.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ijantimicag.2018.09.013","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T14:23:21Z","timestamp":1538058201000},"page":"22-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":187,"title":["Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5905-2695","authenticated-orcid":false,"given":"Matthew E.","family":"Falagas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentia","family":"Athanasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios L.","family":"Voulgaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos A.","family":"Triarides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos Z.","family":"Vardakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0001","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/CMR.00068-15","article-title":"Fosfomycin","volume":"29","author":"Falagas","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0002","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1126\/science.166.3901.122","article-title":"Phosphonomycin, a new antibiotic produced by strains of streptomyces","volume":"166","author":"Hendlin","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2082693","article-title":"Fosfomycin: A first-line oral therapy for acute uncomplicated cystitis","volume":"2016","author":"Zhanel","year":"2016","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0004","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/527442","article-title":"Fosfomycin: use beyond urinary tract and gastrointestinal infections","volume":"46","author":"Falagas","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0006","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1469-0691.2009.02921.x","article-title":"Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation","volume":"16","author":"Michalopoulos","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0007","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijantimicag.2013.09.010","article-title":"Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria","volume":"43","author":"Pontikis","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0008","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4103\/0255-0857.195379","article-title":"Exploring the hidden potential of fosfomycin for the fight against severe Gram-negative infections","volume":"34","author":"Saiprasad","year":"2016","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0009","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1107\/S1744309112006720","article-title":"Structure of MurA (UDP-N-acetylglucosamine enolpyruvyl transferase) from Vibrio fischeri in complex with substrate UDP-N-acetylglucosamine and the drug fosfomycin","volume":"68","author":"Bensen","year":"2012","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0010","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1074\/jbc.M411325200","article-title":"Evidence that the fosfomycin target Cys115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release","volume":"280","author":"Eschenburg","year":"2005","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2018.09.013_bib0011","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000472869","article-title":"Effect of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents","volume":"13","author":"Carlone","year":"1987","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0012","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1574-6968.2010.02049.x","article-title":"Fosfomycin suppresses RS-virus-induced Streptococcus pneumoniae and Haemophilus influenzae adhesion to respiratory epithelial cells via the platelet-activating factor receptor","volume":"310","author":"Yokota","year":"2010","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0013","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ijantimicag.2016.02.001","article-title":"Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature","volume":"47","author":"Vardakas","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0014","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1128\/JB.185.4.1218-1228.2003","article-title":"In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance","volume":"185","author":"McCoy","year":"2003","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00203-009-0468-9","article-title":"Identification of a novel UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Vibrio fischeri that confers high fosfomycin resistance in Escherichia coli","volume":"191","author":"Kumar","year":"2009","journal-title":"Arch Microbiol"},{"issue":"Pt 11","key":"10.1016\/j.ijantimicag.2018.09.013_bib0016","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1099\/00221287-145-11-3177","article-title":"Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis","volume":"145","author":"De Smet","year":"1999","journal-title":"Microbiology"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0017","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nchembio.1289","article-title":"A cell wall recycling shortcut that bypasses peptidoglycan de novo biosynthesis","volume":"9","author":"Gisin","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0018","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/mdr.2014.0036","article-title":"Blocking peptidoglycan recycling in Pseudomonas aeruginosa attenuates intrinsic resistance to fosfomycin","volume":"20","author":"Borisova","year":"2014","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0019","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nm1396","article-title":"Coexpression of virulence and fosfomycin susceptibility in Listeria: molecular basis of an antimicrobial in vitro-in vivo paradox","volume":"12","author":"Scortti","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0020","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s10096-016-2674-0","article-title":"Abrp, a new gene, confers reduced susceptibility to tetracycline, glycylcine, chloramphenicol and fosfomycin classes in Acinetobacter baumannii","volume":"35","author":"Li","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0021","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijantimicag.2009.11.011","article-title":"Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli","volume":"35","author":"Takahata","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0022","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7164\/antibiotics.31.192","article-title":"Two kinds of mutants defective in multiple carbohydrate utilization isolated from in vitro fosfomycin-resistant strains of Escherichia coli K\u201312","volume":"31","author":"Tsuruoka","year":"1978","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0023","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jac\/dkr466","article-title":"Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens","volume":"67","author":"Karageorgopoulos","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0024","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1128\/AAC.47.9.2850-2858.2003","article-title":"Biological costs and mechanisms of fosfomycin resistance in Escherichia coli","volume":"47","author":"Nilsson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.ijantimicag.2018.09.013_bib0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0924-8579(03)00230-9","article-title":"In vitro activity of fosfomycin against gram-negative urinary pathogens and the biological cost of fosfomycin resistance","volume":"22","author":"Marchese","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0026","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7164\/antibiotics.28.906","article-title":"Characterization of spontaneous fosfomycin (phosphonomycin)-resistant cells of Escherichia coli B in vitro","volume":"28","author":"Tsuruoka","year":"1975","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0027","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/jb.110.3.935-944.1972","article-title":"Isolation and characterization of a phosphonomycin-resistant mutant of Escherichia coli K-12","volume":"110","author":"Venkateswaran","year":"1972","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0028","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1128\/AAC.06122-11","article-title":"Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: MurA confers clinical resistance at low fitness cost","volume":"56","author":"Couce","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0029","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1128\/AAC.32.10.1552","article-title":"Formation of an adduct between fosfomycin and glutathione: a new mechanism of antibiotic resistance in bacteria","volume":"32","author":"Arca","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0030","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1110\/ps.03585004","article-title":"Structure of fosfomycin resistance protein FosA from transposon Tn2921","volume":"13","author":"Pakhomova","year":"2004","journal-title":"Protein Sci"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0031","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1021\/bi963172a","article-title":"Fosfomycin resistance protein (FosA) is a manganese metalloglutathione transferase related to glyoxalase I and the extradiol dioxygenases","volume":"36","author":"Bernat","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0032","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/lam.12366","article-title":"Characterization of fosA5, a new plasmid-mediated fosfomycin resistance gene in Escherichia coli","volume":"60","author":"Ma","year":"2015","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0033","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1093\/jac\/dkw177","article-title":"Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli","volume":"71","author":"Guo","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0034","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1472-765X.2011.03016.x","article-title":"Identification of a novel fosfomycin resistance gene (fosA2) in Enterobacter cloacae from the Salmon River, Canada","volume":"52","author":"Xu","year":"2011","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0035","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1128\/AAC.00944-15","article-title":"IncA\/C Plasmid Carrying bla(NDM-1), bla(CMY-16), and fosA3 in a Salmonella enterica Serovar Corvallis Strain Isolated from a Migratory Wild Bird in Germany","volume":"59","author":"Villa","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsle\/fnu018","article-title":"Coexistence of SFO-1 and NDM-1 beta-lactamase genes and fosfomycin resistance gene fosA3 in an Escherichia coli clinical isolate","volume":"362","author":"Zhao","year":"2015","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0037","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/JB.183.7.2380-2383.2001","article-title":"FosB, a cysteine-dependent fosfomycin resistance protein under the control of sigma(W), an extracytoplasmic-function sigma factor in Bacillus subtilis","volume":"183","author":"Cao","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0038","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1021\/bi4015852","article-title":"Structure and function of the genomically encoded fosfomycin resistance enzyme, FosB, from Staphylococcus aureus","volume":"53","author":"Thompson","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0039","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1365-2958.2006.05131.x","article-title":"Identification of Bacillus subtilis sigma-dependent genes that provide intrinsic resistance to antimicrobial compounds produced by Bacilli","volume":"60","author":"Butcher","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijantimicag.2013.11.003","article-title":"Fosfomycin resistance among vancomycin-resistant enterococci owing to transfer of a plasmid harbouring the fosB gene","volume":"43","author":"Qu","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0041","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1574-6968.1991.tb04580.x","article-title":"Characterization of staphylococcal plasmids hybridizing with the fosfomycin resistance gene fosB","volume":"68","author":"Etienne","year":"1991","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0042","doi-asserted-by":"crossref","first-page":"15730","DOI":"10.1021\/ja039307z","article-title":"Mechanistic diversity of fosfomycin resistance in pathogenic microorganisms","volume":"125","author":"Fillgrove","year":"2003","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0043","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/antibiotics2020217","article-title":"Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance","volume":"2","author":"Castaneda-Garcia","year":"2013","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0044","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1021\/bi700625p","article-title":"Structure and mechanism of the genomically encoded fosfomycin resistance protein, FosX, from Listeria monocytogenes","volume":"46","author":"Fillgrove","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0045","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/AAC.44.3.647-650.2000","article-title":"Characterization of the fomA and fomB gene products from Streptomyces wedmorensis, which confer fosfomycin resistance on Escherichia coli","volume":"44","author":"Kobayashi","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0046","doi-asserted-by":"crossref","first-page":"28518","DOI":"10.1074\/jbc.M803709200","article-title":"Crystal structure of fosfomycin resistance kinase FomA from Streptomyces wedmorensis","volume":"283","author":"Pakhomova","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0047","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1128\/AAC.00223-13","article-title":"Heteroresistance to fosfomycin is predominant in Streptococcus pneumoniae and depends on the murA1 gene","volume":"57","author":"Engel","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0048","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/jac\/dkv221","article-title":"In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa","volume":"70","author":"Walsh","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0049","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/j.ijid.2011.07.007","article-title":"The revival of fosfomycin","volume":"15","author":"Michalopoulos","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0050","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/13543780902967624","article-title":"Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies","volume":"18","author":"Falagas","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0051","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/jac\/dkq237","article-title":"Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials","volume":"65","author":"Falagas","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0052","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijantimicag.2009.03.009","article-title":"Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies","volume":"34","author":"Falagas","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0053","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/AAC.02048-13","article-title":"Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods","volume":"58","author":"Perdigao-Neto","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0054","article-title":"Antimicrobial Susceptibility and molecular mechanisms of fosfomycin resistance in clinical Escherichia coli isolates in mainland China","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0055","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/jac\/dks319","article-title":"Prevalence of acquired fosfomycin resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3","volume":"67","author":"Lee","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0056","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1128\/AAC.01834-09","article-title":"Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes","volume":"54","author":"Wachino","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0057","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jgar.2016.11.011","article-title":"Fosfomycin: In vitro efficacy against multidrug-resistant isolates beyond urinary isolates","volume":"8","author":"Demir","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0058","first-page":"1469","article-title":"Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia","volume":"72","author":"Sugianli","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0059","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s15010-016-0910-2","article-title":"Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study","volume":"45","author":"Rossignol","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0060","series-title":"New Trends in Urinary Tract Infections: The Single-Dose Therapy","article-title":"Influence of experimental conditions on in vitro activity of fosfomycin trometamol and emergence of resistant variants","author":"Ferrara","year":"1988"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0061","series-title":"New Trends in Urinary Tract Infections: The Single-Dose Therapy","first-page":"121","article-title":"Microbiological studies of fosfomycin trometamol against urinary isolates in vitro","author":"Lerner","year":"1988"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0062","doi-asserted-by":"crossref","first-page":"e10193","DOI":"10.1371\/journal.pone.0010193","article-title":"Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections","volume":"5","author":"Rodriguez-Rojas","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0063","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/jac\/dkl315","article-title":"Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance","volume":"58","author":"Ellington","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0064","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/JB.184.2.605-609.2002","article-title":"High frequency of mutator strains among human uropathogenic Escherichia coli isolates","volume":"184","author":"Denamur","year":"2002","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0065","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1534\/genetics.105.045526","article-title":"Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli","volume":"171","author":"Denamur","year":"2005","journal-title":"Genetics"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0066","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF01645261","article-title":"Activity of the trometamol salt of fosfomycin in an in vitro model of the treatment of bacterial cystitis","volume":"14","author":"Greenwood","year":"1986","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0067","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cmi.2017.08.023","article-title":"High interindividual variability in urinary fosfomycin concentrations in healthy female volunteers","volume":"24","author":"Wijma","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0068","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijantimicag.2009.08.013","article-title":"Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections","volume":"34","author":"Roussos","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0069","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.44.7.1771-1777.2000","article-title":"Mutation frequencies and antibiotic resistance","volume":"44","author":"Martinez","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jac\/dkq496","article-title":"Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials","volume":"66","author":"Thi","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0071","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijantimicag.2017.05.010","article-title":"Mechanisms of fosfomycin resistance in carbapenem-resistant Enterobacter sp","volume":"50","author":"White","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0072","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijantimicag.2017.02.010","article-title":"Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum beta-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China","volume":"50","author":"Bi","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0073","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5470241","article-title":"Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates","volume":"2017","author":"Ohkoshi","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0074","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijantimicag.2016.08.013","article-title":"Characterisation of fosfomycin resistance mechanisms and molecular epidemiology in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates","volume":"48","author":"Lu","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0075","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3389\/fmicb.2015.01544","article-title":"Prevalence of fosfomycin resistance and mutations in mura, glpt, and uhpt in methicillin-resistant Staphylococcus aureus strains isolated from blood and cerebrospinal fluid samples","volume":"6","author":"Fu","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0076","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135864","article-title":"Characterization of Fosfomycin Resistant Extended-Spectrum beta-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan","volume":"10","author":"Tseng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0077","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijantimicag.2014.08.010","article-title":"Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China","volume":"45","author":"Jiang","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0078","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/jac\/dkp288","article-title":"CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin","volume":"64","author":"Oteo","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0079","first-page":"34","article-title":"[Pathogenecity of fosfomycin-resistant strains isolated from Escherichia coli]","volume":"52","author":"Kasai","year":"1999","journal-title":"Jpn J Antibiot"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2018.09.013_bib0080","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000472870","article-title":"Monuril and modification of pathogenicity traits in resistant microorganisms","volume":"13","author":"Li Pira","year":"1987","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0081","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10096-014-2285-6","article-title":"Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin","volume":"34","author":"Mei","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0082","series-title":"Kucers\u2019 The use of antibiotics","first-page":"935","article-title":"Fosfomycin","author":"Frimodt-Moller","year":"2010"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0083","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jac\/40.3.393","article-title":"Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey","volume":"40","author":"Arca","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0084","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.43.4.789","article-title":"Emergence of fosfomycin-resistant isolates of Shiga-like toxin-producing Escherichia coli O26","volume":"43","author":"Horii","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0076-6879(05)01023-2","article-title":"Fosfomycin resistance proteins: a nexus of glutathione transferases and epoxide hydrolases in a metalloenzyme superfamily","volume":"401","author":"Rigsby","year":"2005","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.ijantimicag.2018.09.013_bib0086","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/AAC.39.7.1569","article-title":"Product of fosC, a gene from Pseudomonas syringae, mediates fosfomycin resistance by using ATP as cosubstrate","volume":"39","author":"Garcia","year":"1995","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918302723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918302723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:32:37Z","timestamp":1760376757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918302723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0924857918302723"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.09.013","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}